Effects of Probiotics in Immune System of Healthy Adults

NCT01479543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2014-09-05

Study results available
· View outcomes & findings →

Summary

The present report describes the design of a clinical trial performed on healthy adult individuals to check whether the daily intake of the new Hero strains contribute to intestinal colonization, under safe and tolerable conditions, with a positive contribution to health and wellbeing of healthy individuals.

Daily intake of one or several probiotic strains, (CNCM I-4034, CNCM I-4035, CNCM I-4036), increases intestinal microbiota in healthy adults, being safe and well tolerated. The regular intake has positive effects on the gastrointestinal and immune system.

Conditions

  • Conditions Influencing Health Status

Interventions

OTHER

Probiotic CNCM I-4034

Probiotic CNCM I-4034 in a concentration of 9x10E9 cfu (colony forming unit) per day during 28 days.

OTHER

Probiotic CNCM I-4035

9x10E9 cfu (colony forming unit) per day during 28 days.

OTHER

Probiotic CNCM I-4036

9x10E9 cfu (colony forming unit) per day during 28 days.

OTHER

Probiotics CNCM I-4035 and CNCM I-4036

9x10E9 cfu (colony forming unit) per day during 28 days.

OTHER

Placebo

Placebo capsule for 28 days.

Sponsors & Collaborators

  • Universidad de Granada

    collaborator OTHER
  • University of Valencia

    collaborator OTHER
  • Universidad de Murcia

    collaborator OTHER
  • Hero Institute for Infant Nutrition

    lead INDUSTRY

Principal Investigators

  • Pedro Abellán, PhD · Hero Institute of Infant Nutrition

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01479543 on ClinicalTrials.gov